About 95% of the "so called CMO" products on the market today are "Cetyl Myristoleate" or "Cetylmyristoleate". These products are properly referred to CM. They are not the true CMO.
CM products come in a gel capsule full of oil and look much like a Vitamin E capsule. The true CMO, like CMO II, is Cerasomal-cis-9-cetylmyristoleate and comes in longer capsules full of a brownish white powder.
CM products, marketed as "CMO" are generally very cheap and may be "synthetically" made from chemicals or vegetable oil, and if so, are totally ineffective and may be harmful!
Genuine CM, if you can tell genuine CM from fraudulent CM, is the original substance discovered by Dr. Diehl. However, in the CM form, it is a virtually indigestible without taking additional enzymes and even then, to be the slightest bit effective, you have to take very large quantities of CM because so much of it ends up in the toilet.
Beware of CM products, claiming to be CMO, bragging about more mgs, or even grams, of CMO. First of all they are not CMO, they are CM, and secondly they are playing the numbers game to cover a lack of absorbability, --- trying to make you believe more is better.
Since the introduction and phenomenal success of Dr. Len Sands naturally derived, non toxic, Cerasomal-cis-9-cetylmyristoleate (Trade Marked CMO for marketing purposes) in 1994, the market has been swamped with hundreds of "knock off" products under what has become a generic name ---- "CMO".
In the majority of cases, when a product is such a success that its name becomes "generic", the original product tends to remain the best "value" for your money.
The good doctor discovered that a certain species of albino laboratory mice were resistant to induced arthritis. Upon further study, he isolated the unique substance found in these mice that provided their protection. That substance was a oily compound he called "Cetylmyristoleate" (CM).
Further experimentation indicated that when "Cetylmyristoleate" (CM) was injected into humans with arthritic joints, the condition improved. However at the time, there was no economical method to produce "Cetylmyristoleate" (CM) in quantity, and if there was, how would he market an injectable product to the mass market.
Further experimentation with oral ingestion of "Cetylmyristoleate" (CM) proved to be problematic as "Cetylmyristoleate" (CM) was very indigestible and the effects with oral administration were much less than dramatic. Therefore the project was dropped for years.
Dr Sands was fascinated with Dr Diehl's work and reasoned if "Cetylmyristoleate" (CM) could be reformulated into a digestible form, without losing it properties, he would have a mass marketable product.
Through experimentation, Dr Sands was able to produce an analog (a new structural form) of "Cetylmyristoleate" (CM) that was a crystalline powder. Being in crylalline form, it fractures within the small intestine, thus presenting billions of smaller surfaces so the CM can easily be absorbed into the blood stream as a nutrient without additional enzymes. Thus was born the product called Cerasomal-cis-9-cetylmyristoleate, or CMO for short.
Cerasomal-cis-9-cetylmyristoleate (CMO II) demands a multitude of precise temperature and pressure extraction methods, over time, to isolate the ten natural fatty acids (nutrients) and formulate them into a crystalline digestible powder form that is absorbable and effective. Therefore, CMO II is to wine as CM is to grape juice.
When a product is hot, others will enter the market to grab some of the action and profits. Therefore today the 95% of "CMO" products on the market today are cheap "Cetylmyristoleate" (CM) or "cetyl myristoleate" (CM), which if they are not synthetic, are the same product Dr Diehl determined not to be effective when taken orally.
CM products"Cetylmyristoleate" and "Cetyl myristoleate" products generally retail from $9 to $52.
My product, named CMO II to reflect my expertise that comes with it, is manufactured for me by Dr Len Sands' son to Dr Len Sands precise original specifications. You can't purchase more "value" and "effectiveness" than CMO II, period.